Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome.

Citations

SCOPUS

15

초록

Terlipressin is a vasopressin analogue that is widely used in the treatment of hepatorenal syndrome or variceal bleeding. Because it acts mainly on splanchnic vessels, terlipressin has a lower incidence of severe ischemic complications than does vasopressin. However, it can still lead to serious complications such as myocardial infarction, skin necrosis, or bowel ischemia. Herein we report a case of severe ischemic bowel necrosis in a 46-year-old cirrhotic patient treated with terlipressin. Although the patient received bowel resection, death occurred due to ongoing hypotension and metabolic acidosis. Attention should be paid to patients complaining of abdominal pain during treatment with terlipressin.

키워드

Terlipressin; Necrosis; Hepatorenal syndrome; bilirubin; creatinine; drug derivative; lypressin; terlipressin; vasoconstrictor agent; article; blood; case report; chemically induced disorder; computer assisted tomography; electrocardiography; fatality; hepatorenal syndrome; human; intestine; intestine mucosa; liver cirrhosis; male; middle aged; necrosis; pathology; Hepatorenal syndrome; Necrosis; Terlipressin; Bilirubin; Creatinine; Electrocardiography; Fatal Outcome; Hepatorenal Syndrome; Humans; Intestinal Mucosa; Intestines; Liver Cirrhosis; Lypressin; Male; Middle Aged; Necrosis; Tomography, X-Ray Computed; Vasoconstrictor Agents
제목
Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome.
저자
Kim H.R.; Lee Y.S.; Yim H.J.; Lee H.J.; Ryu J.Y.; Lee H.J.; Yoon E.L.; Lee S.J.; Hyun J.J.; Jung S.W.; Koo J.S.; Choung R.S.; Lee S.W.; Choi J.H.
DOI
10.3350/cmh.2013.19.4.417
발행일
2013
유형
Article
저널명
Clinical and Molecular Hepatology
권
19
호
4
페이지
417 ~ 420